Podcast appearances and mentions of Charles River

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Philip Macnabb, Chief Executive Officer at Curia. Your host, Raman Sehgal, speaks with Phil about the pharmaceutical and biotechnology supply chain, covering: Over 25 years of working with private equity — and why PE is ultimately about building sustainable value. The common threads he looks for as a CEO of any new organisation, and why employees often know the answer first. Navigating the COVID comedown at Curia, making major network changes, and refocusing on biotech clients. Why CDMOs are really selling trust as the service, not just manufacturing — and how that plays into customer intimacy and reputation. Betting on the trend toward small batch sizes and personalised medicines in biotech and pharma. Phil leads Curia in pursuit of its mission to improve patients' lives, applying end-to-end capabilities and deep scientific expertise to advance customers from idea to impact. He brings more than 20 years of private-equity leadership experience to Curia, including the last decade in healthcare. Most recently, he served as Chief Executive Officer at Epsilon Global, a company he co-founded. In addition to his healthcare experience, he has held senior positions in technology, distribution, and consumer products. Phil has a proven track record of sharpening companies' core value proposition, enhancing the customer experience, and building organisations with real, lasting value. Phil earned an MBA from the University of Chicago and a BS in Business Administration from Purdue University.   Molecule to Market is sponsored by Bora Pharma and Charles River, and supported by Lead Candidate. Please subscribe, tell your colleagues, and help us celebrate the value of the global life science outsourcing space. We'd also appreciate a positive rating!

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Lars Petersen, President & Chief Executive Officer at FUJIFILM Biotechnologies.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Lars, covering: The difficult decision to leave Novo Nordisk and make the jump from one great company to another in Genentech/Roche. How leaving a Biogen site led him to step away from big pharma after 25 years and transition to the CDMO side. How Fujifilm's culture of innovation, technology, quality, and people runs through the Biotechnologies division — and why empowerment and culture should never be compromised. Why the duplication of its CDMO sites globally, all running on the same kojoX platform, is truly differentiating. Why he believes the need to standardise, scale, and globalise drug production in a consistent, efficient, and traceable way is key to the future of the supply chain. Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by Lead Candidate.    Lars Petersen, CEO of FUJIFILM Biotechnologies, is recognized as a visionary leader in the life science sector, commanding a global contract development and manufacturing organization (CDMO) with nearly 5,000 employees spread across Denmark, UK, USA, and Japan.    Distinguished for his strategic vision and a "people first" philosophy, Lars has profoundly impacted the company and the industry. His leadership journey saw him rise from Chief Operational Officer & Senior Vice President at the Danish site, where he established an empowering culture, to CEO, promoting transparency across all operations. Since his global leadership appointment in June 2023, Lars has been instrumental in cultural transformation, integrating a "people first" approach across FUJIFILM Biotechnologies' global facilities regardless of geographical differences.   Prior to his appointment as CEO, Lars was responsible for the Global Large Scale Commercial operation including full profit and loss accountability as well as the responsibility for over $6.2 Billion global expansions both in Hillerød, Denmark, and Holly Springs, North Carolina, USA.   Previously, Lars has held leadership positions with Biogen, Genentech/Roche, Novo Nordisk, Novozymes and NNE, and he has successfully executed projects in Europe, China and the US.   Lars holds a master's degree from the Technical University of Denmark.   Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! 

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Matt Lowe, CEO at performance.io/ Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Matt, covering: Seeing a niche in SEO, within the healthcare space... and opting to take a risk and jump our of big pharma. Why healthcare agency models are built for agencies, not pharma. The mass wastage of big pharma spend when it comes to the commercial launch. How you should be thinking about generative search and customer experience... and why Google is still dominating the search landscape. Founder and CEO at performance-io (PIO), Matt has been the driving force behind bringing search engine optimization (SEO) into pharma. With more than 22 years in the highly regulated industry pharma space, spanning client-side and agency roles, he is responsible for a number of industry firsts, all focused on helping pharma companies to revolutionize their customer engagement.   Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Michael Scholl, Chief Executive Officer and Co-Founder at Leukocare. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Michael, covering: The influences, and potential for impact that led him down a path of entrepreneurship. Chronicling the ups and downs of over 20 years in business at Leukocare. Pivoting to be a specialist CRO/CDMO with a differentiation in data-driven, formulation development... leading to a record year in 2024. How the delay in decision making in the market is impacting the pharma services space. Michael Scholl is the Co-founder and Chief Executive Officer of Leukocare, a leading CDMO specializing in formulation and drug product development services for sterile injectables. With more than 20 years of leadership experience in the life sciences industry, Michael is responsible for shaping the company's strategic direction and cultivating partnerships with biopharmaceutical clients around the world. Under his leadership, Leukocare has established itself as a trusted partner in advancing complex biologics from early development to market-ready drug products. He began his career as a business consultant at the Boston Consulting Group (BCG), he holds a degree in Industrial Engineering from the Technical University of Berlin and studied at the Haas School of Business, University of California, Berkeley.   Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.   Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Kaan-Fabian Kekec, Partner in Healthcare and Life Sciences at Simon-Kucher. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kaan, covering: Being on the sunny side of consulting, and helping clients unlock growth. What makes a key strategic partnership both from a CDMO, and a sponsor perspective. The taboo subject of pricing and how it can be used to help unlock commercial positioning, and excellence. Common mistakes in BD teams, and the importance of value positioning. The hottest segments in the market right now, and some of the competitive drivers in today's market. Kaan leads the firm's Healthcare B2B and Pharma Services business globally, encompassing CDMOs, CROs, bioprocessing solutions, drug delivery, packaging, and more. He specializes in delivering end-to-end commercial strategies for CDMOs, advising on growth initiatives and supporting clients throughout the entire lead-to-deal process—from marketing and sales to proposal management and deal optimization. Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.  Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

What does it really take to qualify for the Boston Marathon? Grit? Speed? A fast course? How about… running the same loop ten times in a row? This past Sunday, Amy ran the Charles River Invitational, a 2.6 mile loop around the Charles River.  Same scenery. Not much crowd support. Pouring rain. One last shot on the last day to qualify for Boston for 2026.  We break down the strategy- from pacing to nutrition; what it felt like to run the same loop over and over; and why Boston is still the mecca of all marathons out there for runners!   

Boston is one of those cities that just gets under your skin in the best way possible. Equal parts old-school history and modern-day hustle, it's where cobblestone streets meet glass skyscrapers, where the story of America was born, and where you can eat your body weight in lobster rolls without a shred of regret.Founded in 1630 by English Puritans, Boston has played host to some of the most pivotal events in U.S. history—the Boston Tea Party, the Battle of Bunker Hill, and even the first public park in America. Today, it's a vibrant mix of college-town energy, cutting-edge innovation, and diehard sports fandom (you'll never hear a “Go Sox!” shouted with more passion than here).I recently spent five days exploring Boston like a local, armed with a loose plan, comfy walking shoes, and an appetite big enough to conquer the city's legendary food scene. Here's how it all went down—my perfect Boston adventure. Day 1: Arrival & First Taste of the CityFlying into Logan International Airport is a breeze—it's practically right in the city. But here's your first Boston pro-tip: skip renting a car if you can. Boston traffic is next-level chaotic, parking is expensive, and the city is surprisingly walkable. Between the subway (locals call it “the T”) and Uber, you'll get around just fine.Of course, I had to test the rental car waters—$368 for two days of a Nissan Rogue—and let me tell you, the line alone made me question my life choices. If you do rent, book with a company that lets you walk straight to the garage and grab your car. Otherwise, hop in an Uber and save yourself the headache.Where to StayI split my stay between two totally different vibes:Hampton Inn & Suites Watertown – Budget-friendly ($100 a night) and great if you don't mind being just outside the city. Parking in Boston can run you $30 a day, so staying here helped balance the budget.Copley Square Hotel (FOUND Hotels) – Right in the heart of Back Bay, this historic gem ranges from $300–$600 a night. My corner-view studio overlooked the breathtaking Trinity Church at sunset, and it felt like waking up inside a postcard. Designed in 1877 by architect H.H. Richardson, this place is dripping with Richardsonian Romanesque charm—arched windows, rough stone, and colorful details. Around Copley, you'll also find:Fairmont Copley Plaza (1912) – A Gilded Age beauty and part of the Historic Hotels of America.Boston Public Library McKim Building (1895) – A Renaissance Revival masterpiece with white marble halls and free daily tours at 2 pm. Don't skip it; the architecture is jaw-dropping.Old South Church (1873) – A National Historic Landmark in Northern Italian Gothic style, complete with multicolored stone and a towering bell.John Hancock Tower (1976) – Boston's tallest skyscraper at 790 feet, shimmering in blue glass.After a long travel day, we celebrated our first night with dinner at Lolita Cocina & Tequila Bar. Order the lobster guacamole and grilled elote—and when in Boston, remember the golden rule: always order seafood. Steaks are for later. Oh, and if you see Scrod on the menu? Don't panic. It's not a weird mythical fish; it's just the white catch of the day—usually cod or haddock. Day 2: Walking Through HistoryIf Boston had a greatest hits album, it would be the Freedom Trail—a 2.5-mile path that connects 16 historic sites and tells the story of America's revolution. You can do it self-guided, join a regular tour, or go all out with an actor-led adventure (think Paul Revere cosplay).Morning Coffee & Boston CommonStart with caffeine at Thinking Cup Coffee Bar, then wander into Boston Common, the oldest public park in America (1634). It's massive, filled with monuments, and now home to the striking Embrace Memorial, honoring Martin Luther King Jr.From there, the trail unfolds like a time machine:Massachusetts State House (1798) – Charles Bulfinch's golden-domed wonder, still home to the state government.Park Street Church (1809) – Once Boston's tallest landmark, it sits on the site of the city's old grain storage.Granary Burying Ground (1660) – Final resting place of heavyweights like John Hancock, Sam Adams, and Paul Revere.King's Chapel & Burying Ground (1686) – Boston's first Anglican church, with over 330 years of history.Boston Latin School Site (1635) – The oldest public school in America; today it's marked by a Benjamin Franklin statue.Old Corner Bookstore (1718) – Once the publishing hub of legends like Hawthorne, Longfellow, and Thoreau. Now… a Chipotle (I wish I were kidding).Lunch at Union Oyster HouseBy now, you'll be starving. Enter Union Oyster House, America's oldest continuously operating restaurant (since 1826). The JFK booth is a must-sit, and yes—you're ordering a lobster roll.Afternoon: Monuments & Baseball MagicDon't miss the New England Holocaust Memorial—six glass towers etched with survivor stories, both sobering and moving.Then, if you're lucky enough to visit in season, cap off your night at Fenway Park. Whether it's catching a Red Sox game, snagging early batting practice passes, or just soaking up the energy at Cask 'n Flagon across the street (hot tip: persistence pays when getting a table here), Fenway is pure Boston. Day 3: More Freedom Trail & North End TreatsStart with breakfast at Quincy Market, the ultimate food hall. Then dive back into history:Old South Meeting House (1729) – Where colonists debated tea taxes and kicked off the Boston Tea Party.Old State House (1713) – Boston's oldest public building, central to colonial politics.Boston Massacre Site (1770) – A simple cobblestone marker for one of America's darkest sparks of revolution.From here, pop back into Quincy Market for another lobster roll (yes, it's worth a second one).Keep following the trail:Faneuil Hall (1742) – “Cradle of Liberty” where fiery speeches once filled the air. Today, it's mostly a giant souvenir shop, but the echoes of history remain.Paul Revere House (1680) – The patriot's humble home. Tours are intimate but no photos allowed inside.Old North Church (1723) – Where lanterns signaled “One if by land, two if by sea.” Take the tour to see the crypt and bell chamber.Cannoli TimeBoston's North End is an Italian dreamland, so refuel at Mike's Pastry with a giant cannoli. (Pro tip: get a few extra to-go. You'll thank me later.)End the night at Bell in Hand Tavern (1795), America's oldest continuously operating tavern. It's rowdy, it's historic, and it's the perfect spot for your nightcap. Day 4: Big Battles & Big ShipsIf your legs aren't jelly yet, tackle the Bunker Hill Monument. Climb the 294 steps for killer views of the city.From there, wander over to the USS Constitution, aka “Old Ironsides,” the oldest commissioned warship afloat. The ship and museum are free and make for an epic history-meets-maritime adventure.For a modern twist, hop in an Uber to the JFK Presidential Library & Museum—a sleek, inspiring deep dive into the Camelot era. Afterward, head to Sam Adams Brewery in Jamaica Plain. Tours start at $10, include tastings, and give you all the Boston beer vibes. Day 5: Art, Rainy-Day Magic & Sunset on the HarborBoston weather can turn on a dime, so I saved indoor treasures for day five.Morning: Museum of Fine ArtsThe MFA is massive, so choose wisely:Jewelry lovers: Beyond Brilliance exhibit (ancient to modern sparkle, with Chanel and Bulgari highlights).Classicists: Greek, Roman, and Byzantine collections.Painters-at-heart: Dutch & Flemish gallery with works by Rembrandt and Rubens.Quirky souls: Dollhouses and temporary Van Gogh exhibits.Fuel up at the museum café before heading out.Evening: Sunset Harbor CruiseOur trip ended on the water, with a Boston Harbor sunset cruise. Even in the rain, the top deck views were worth it. There's a buffet dinner, DJ, and plenty of space to dance—because no Boston trip is complete without one last celebration. Other Boston Must-Dos (If You Have Time)Duck Boat Tour – Amphibious buses that roam the streets then splash into the Charles River. Cheesy? Yes. Fun? Also yes.Cheers Pub – Grab a drink where everybody used to know your name.Green Dragon Tavern – A revolutionary haunt turned modern-day pub.Boston Burger Co. or Wahlburgers – Because you need at least one outrageous burger on this trip. Final ThoughtsBoston is the kind of city that can be done in a weekend but deserves a week. It's history you can touch, seafood you'll crave long after, and neighborhoods that feel like they've been waiting just for you.If you only had one day, I'd say walk the Freedom Trail—it's Boston in a nutshell. But if you want to experience the city like a local? Take your time, eat the lobster rolls, get lost in the cobblestone streets, and maybe—just maybe—let Fenway turn you into a Red Sox fan for life.Boston, you're wicked awesome.

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Adam Siebert, Managing Director and Partner at L.E.K. Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering: Adam's journey from academic to commercial, and what helped him transition into 'life science enablers". How pandemic demand has left our sector with a huge over capacity issue and market imbalance. Some positive signals for the second half of 2025 after a period of geopolitical chaos, and a bumpy rollercoaster. Even thought biotech funding has largely returned... how decreasing clinical trials, a shifting of therapeutic focus, and the concentration of investments on fewer, higher value deals is impacting pharma services. The value of building a reputation in one in-demand modality area before extending into other modalities. And why the CDMO is at an inflexion point... Adam is a Managing Director and Partner in L.E.K. Consulting's New York office and a member of the Life Sciences practice. He has been with L.E.K. for over eight years, and has experience across diagnostics and research tools, bioprocessing and pharma services, and emerging, mid-cap and large pharma. Adam has helped a number of clients in the life sciences industry with growth strategy, life cycle management, portfolio optimization and M&A projects. Adam holds a Bachelor of Science from Boston College and a Ph.D. from the Perelman School of Medicine at the University of Pennsylvania.    Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Stephen Dilly, Chairman, President and Chief Executive Officer at Codexis. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Stephen, covering: His journey of almost 40 years in the industry, including 20 years as a CEO. Leading two therapeutic companies to two, successful, $billion+ exits... Not making snap judgements and instant opinions early on in your role as a senior leader. Why he took on the challenge of leading Codexis at this phase of his career. The importance of values as guiding principles, and spending in-person time with your team. As President & CEO of Codexis since August 2022, Stephen brings more than three decades of executive management experience in the biopharmaceutical industry. Most recently, he served as President and CEO of Sierra Oncology (NASDAQ: SRRA) through its recent sale to GlaxoSmithKline for $1.9 billion.  Previously, Dr. Dilly served as CEO of Aimmune Therapeutics, acquired by Nestle Health Science for $2.6 billion. Dr. Dilly has served in executive roles at Genentech, Chiron and SmithKline Beecham and has been associated with the development, approval and launch of more than twenty marketed drugs across multiple therapeutic areas. He holds both an MBBS and a PhD in Cardiac Physiology from the University of London.   Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.    Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Tara Dougal, Event Director - Pharma (CPHI Europe). Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tara, covering: How CPHI has changed over the last decade of Tara being involved in the show. The challenge of dealing with the volume of over 60k people turning up for three days at a major European city. Being tasked with running one of Informa Markets' largest global shows. How to make the most of this year's CPHI Europe before, during and after the show. The hidden gems of opportunity that you might be missing out on at CPHI. Tara brings over 12 years of extensive event management experience spanning roles in New York, London, and Amsterdam. She previously held the position of Content Director before advancing to her current leadership role. Her expertise extends beyond event management to content production, where she has demonstrated exceptional skill in creating high-quality content and building strategic relationships with clients and partners. At CPHI, Tara plays a crucial role in creating connections and inspiring partnerships across the global pharmaceutical community, championing innovation at the heart of pharma through both in-person and online events. Her international experience and industry insight contribute significantly to Informa Markets' position as the world's leading exhibitions organiser, delivering over 550 market-leading events annually.   Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.

In the first episode of Season 4 of The Object of History, we briefly discussed the filling in of the Charles River bay when we introduced listeners to the Historical Society's building at 1154 Boylston Street. On this bonus episode, we invited one of our 2025 Dean W. Eastman Undergraduate Library Residents, Vivienne Charpentier, to dive deeper into history of the Back Bay. Vivienne tells us more about the Back Bay and then joins Chief Historian Peter Drummey on a walking tour of the neighborhood. Learn more about episode objects here: https://www.masshist.org/podcast/season-4-bonus-episode-Back-Bay  Email us at podcast@masshist.org. Listen to "1154 Boylston Street". Episode Special Guest: Vivienne Charpentier was a Dean W. Eastman Undergraduate Library Resident in the 2025 Academic Year. They will begin their master's program in Library & Information Studies at the University of Rhode Island in the fall of 2025. This episode uses materials from: Canoe by Podington Bear (Attribution-NonCommercial 3.0 International)        Psychic by Dominic Giam of Ketsa Music (licensed under a commercial non-exclusive license by the Massachusetts Historical Society through Ketsa.uk)        Curious Nature by Dominic Giam of Ketsa Music (licensed under a commercial non-exclusive license by the Massachusetts Historical Society through Ketsa.uk)

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Andrea Wagner, CEO at PharmaPhixx. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andrea, covering: Building a 'not very pretty' business, to an eventual exit after 10 years The reluctant founding of Berkshire Sterile Manufacturing (Now Sharp)...making new mistakes on her encore journey of growth and a second exit Why company leaders should think of decision-making like trees Pro business development tips from a seasoned entrepreneur with growth hard-wired into her Her views on the current market and what opportunities lie ahead for the brave Dr. Andrea N. Wagner is a serial entrepreneur renowned for co-founding and advancing two contract sterile manufacturing companies, with her latest venture acquired by Sharp Services in October 2023. She passionately advocates for women in business, serving on the board of Women Entrepreneurs Grow Global (WEGG), co-founding Herizon Funding to support women-owned businesses, and contributing as an advisory board member at the Boston Museum of Science. As CEO of PharmaPhixx and founder of the sweater brand LuxLined in 2024, Andrea continues to diversify her business interests. Additionally, she established the Andrea Wagner Scholarship Fund to support young women pursuing STEM degrees. Currently, she is writing a book, focusing on empowering women in STEM to ascend to leadership roles. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.

How do researchers keep our dirt clean? How can earthworms, duckweed, birds and bees help us ensure environmental safety? Find out now by listening in with our experts from Charles River's Hungarian site - Szabolcs Gáty and David Esdaile.

A waring is out from the City of Boston to avoid part of the Charles River, police in Montana are searching for a gunman who killed four people at a bar, and the big college move-in day is under a month away.

The White House said times up to cut a tariff deal, federal court denied Boston Marathon bomber's appeal, and harmful algae bloom closed off the Charles River. Stay in "The Loop" with WBZ NewsRadio. 

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Adam Sherlock, CEO at Qinecsa. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering: How he developed his professional CEO skills over the years to complement is entrepreneurial spirit The combination of micro and macro factors that help determine when the right time is to go to market, and sell The importance of your gut instinct when assessing M&A targets... and painting a picture of why the world is a better place when together Several attempts at failing to retire... and being tempted back into another pharma services CEO role How R&D services will be impacted by AI, and why we all need to be eating our own lunch Adam is a serial entrepreneur and executive leader with nearly 40 years of experience in the international life sciences industry, particularly in bio/pharma, IVD, and medical device sectors. A scientist by training, he has led successful growth and M&A efforts, creating exceptional value in four private equity-backed businesses over the past decade.  Adam is also a sought-after NED, Chair, and independent advisor. Currently, he serves as CEO of Qinecsa, a global provider of pharmacovigilance technology and services. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.

In this special episode of Molecule to Market, recorded at this year's CDMO Live in Rotterdam, industry leaders come together to assess the evolving state of the contract development and manufacturing sector. Raman is the panel moderator, joined by:  Gil Roth - PBOA Dr. Jim Li - BioDuro Sundia Kaan-Fabian Kekec - Simon-Kucher They unpack cautious optimism in the face of lingering market uncertainties and geopolitical tension, you'll hear: How CDMOs are adapting to early-stage funding strain and evolving pricing models The impact of rising interest rates, tariffs, and global trade policy on pharma outsourcing Capacity and talent constraints facing CDMOs in new therapeutic modalities Why integrated models and scenario planning are key to future-proofing operations This episode offers timely insight into the challenges and opportunities shaping the next phase of growth for CDMOs worldwide. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.

No Café com Investidor, Camilo Marcantonio, fundador da Charles River Capital, explica sua tese e fala de seu portfólio, que inclui Dexco, Banco ABC, Tupy, BrasilAgro e Ternium

For this exciting conversation, I am joined by NanoPalm CEO and co-founder Dr. Ali Alhasan and by Charles River Executive Director Ramin Baghirzade, who joins us to talk about Charles River's incubator program for startups like NanoPalm. Alhasan and his co-founder, Dr. Samar Alsudir, began NanoPalm to help reach rare disease patients who could benefit from advanced gene therapies. NanoPalm is the first company to conduct a gene therapy clinical trial in Saudi Arabia, with plans for many more treatments in the works. Listen now to learn about the trial, Charles River's incubator program, and about the current state of biotech startup in Saudi Arabia.

What if a mouse could help shape the future of cancer treatment? In this episode of Sounds of Science, host Mary Parker speaks with Julia Schüler, DVM, PhD, Research Director and Therapeutic Area Lead for Oncology at Charles River. Julia shares how patient-derived xenograft (PDX) models—often described as “avatars” of human tumors—are transforming preclinical oncology research. From preserving tumor heterogeneity to improving translational relevance, PDX models are accelerating the discovery of more effective, personalized therapies. Tune in as we explore how these advanced models are driving innovation across the drug development pipeline—from target discovery to clinical trial design.Show NotesPDX Tumor Organoids : A New Tool in Drug Discovery Testing Realm Organoids: Some Assembly Required Patient-Derived Xenografts- PDX Models 3D Tumor Models In Vitro PDX Assays 

Today:The Charles River Jazz Festival occurs July 12 at the Herter Park Amphitheater on Soldier's Field Road. More info and and to reserve a free ticket go to BostonJazzFoundation.org. Festival founder Seba Molnar joinswith foundation co-founder Moriah Phillips, and vice-chair Jess Curin. They all perform.And, retired federal judge Nancy Gertner reviews the Supreme Court's end-of-term rulings released today, including limiting orders blocking the Trump administration's birthright citizenship ban.

Join me, Charles River's Miriam Guest, and independent consultant Vanessa Figueroa as we tackle the role of a microbiologist in drug manufacturing. Who is keeping patients safe from contamination, and how are they making sure our life saving drugs are not contaminated? How is manufacturing like yoga? Find out by listening now!

On April 18, 1775, a Boston-based silversmith, engraver, and staunch anti-British political operative named Paul Revere set out on the most famous horse ride in American history. A century later it inspired the poem and legend of "The Midnight Ride of Paul Revere." But the story is deeper and richer than we've all assumed. Acclaimed writer and editor Kostya Kennedy, through extraordinary and extensive research, has uncovered new and enlightening information on that amazing - including the women who were involved and African Americans in Boston - event presented now in his new book, THE RIDE: Paul Revere and the Night That Saved America (St. Martin's Press, On Sale Date 3/25/25, $30.00). Revere was not the only rider on the night of April 18, 1775, but he was by far the most critical. The Patriots best and most trusted "express rider" he had already completed at least 18 previous rides throughout New England, disseminating intelligence about British movements. But this ride was like no other, and its consequences in the months and years following - as the American Revolution transitioned from isolated skirmishes to a full-fledged war - became one of our founding tales. In THE RIDE, Kostya Kennedy presents a dramatic new narrative of the events of Revere's ride, informed by fresh primary and secondary research into archives, family letters and diaries, contemporary accounts, and more. What he found are never before, or rarely, discussed events, before and after the ride, including: *On the night of the ride, Paul Revere was already the go-to rider for the revolution, called upon to make the most critical rides: in December 1773 he rode hundreds of miles south to New York and Philadelphia to deliver news of The Boston Tea Party.*Revere never said, "The British are coming!" during the ride.*On the night of the ride, Revere rode on a borrowed horse that was then taken from him by British officers; Revere never saw the horse again.*The "sea," in "one if by land, two if by sea," refers to the Charles River.*Revere intentionally did not carry his pistol on the night of the ride, which may have saved his life.*At the start of the ride, Revere was rowed quietly over the Charles River from Boston to Charlestown, along the way eluding lookouts stationed on a British warship.*Other riders galloped through the countryside that night carrying the alarm and nearly all of them were set in motion by Revere's alarm.*Only one other rider departed from Boston, William Dawes, who left over land across Boston Neck; as Dawes got past British guards he pretended he was a drunk country bumpkin. Kennedy's work shows the Revere ride to be vastly more complex than is usually portrayed. It was a coordinated ride of some 40 men that included near-disasters, capture by British forces, and ultimately success. While Paul Revere was central to the ride and its plotting, the author reveals the myriad other men - and women! - who proved crucial to the events that helped set in motion what would lead to America's independence. Thrillingly written in a dramatic heart-stopping narrative, THE RIDE re-tells the essential American story of our nation's awakening for a new generation of readers. Become a supporter of this podcast: https://www.spreaker.com/podcast/arroe-collins-unplugged-totally-uncut--994165/support.

What happens when cutting-edge science meets compassion? In this episode of Sounds of Science, host Mary Parker sits down with two pioneers reshaping the future of research: Elizabeth Nunamaker, Executive Director of Global Animal Welfare and Training at Charles River, and Dr. Megan LaFollette, Executive Director of the 3Rs Collaborative. From digital biomarkers to environmental health monitoring, they reveal how innovation and collaboration are redefining what's possible in animal welfare — and raising the bar for ethical, high-quality research. Tune in to explore the tools, strategies, and bold ideas driving meaningful change across the scientific community.Show NotesAdvancing Alternatives | Charles RiverEvolving Animal Welfare: Science, Ethics, and Innovation | Sounds of Science Can You Practice High-quality Science and 3Rs? | Eureka BlogAnimals in Research | Charles RiverResearch Models & Services | Charles River

Werewolves and DemonsStory 1In Stone River, a seemingly typical American town with familiar seasonal events like carnivals and Christmas parades, a dark secret sets it apart: strict rules govern residents' lives to protect them from monstrous, bipedal wolf-like creatures that inhabit the surrounding woods and prey on humans. These rules, such as never traveling alone or leaving windows open at night, stem from centuries-old local lore about these creatures, which have claimed numerous lives, including newcomers like E.G. Parker and his crew in the 1940s, and local teens Alan and Lisa in the 1970s, whose gruesome deaths haunt the town. A 63-year-old lifelong resident, recounts the town's history and the rules' origins, which predate his grandmother's tales of a time without them. His own harrowing encounter with one of these creatures, when his truck runs out of gas on a lonely road, nearly costs him his life.Story 2In the summer of 1972, a 14-year-old boy fishing at a lagoon beneath the dilapidated "Monkey Bridge" near the Charles River discovers an old, ornate watch entangled in weeds, which he cleans and cherishes, unaware of its sinister history. That night, a terrifying dream places him on the bridge, reliving the fatal fall of a boy his age, and he awakens to see the boy's ghost pleading for help, with the watch mysteriously stopping at 4:18. The next day, compelled to climb the bridge, he encounters the ghostly boy again, tormented by demonic gremlins who mock him into a deadly crossing, revealing the watch's curse: it lures young boys to their deaths, manipulated by these malevolent entities. With his grandfather's help, a war veteran familiar with such evil, they uncover the watch's connection to Timothy Burns, a boy who drowned decades ago, and destroy it at his grave, banishing the gremlins and freeing the trapped souls. Now an old man and veteran himself, the narrator reflects on the ongoing battle against such soul-stealing evil, which persists in modern times through technology, as he vigilantly protects his grandson from similar unseen dangers.Become a supporter of this podcast: https://www.spreaker.com/podcast/what-if-it-s-true-podcast--5445587/support.

In this episode, Aniket Bhardwaj, Vice President at Charles River Associates, shares insights on the growing role of cybersecurity in business and national security. 

In this episode, Aniket Bhardwaj, Vice President at Charles River Associates, shares insights on the growing role of cybersecurity in business and national security. 

This is the second of two "Sidebar" episodes in honor of the 250th anniversary of Paul Revere's famous ride, which we will celebrate on the night of April 18 by putting two lights in a window of our house.  Last time we explored the prelude to the ride in the months before the final crisis that triggered the march of the British "Regulars" on Lexington and Concord. This episode is the story of Paul Revere's "midnight" ride on the night of April 18-19, 1775, including the famous lanterns of Old North Church, the fraught trip across the Charles River under the guns of HMS Somerset, his spectacular horse Brown Beauty (one of the great equine heroes of American history), the "waking up the institutions of New England" that night in raising the alarm not just on the road to Lexington and Concord but throughout eastern New England, and his astonishing capture and release. And, sure, William Dawes and Dr. Samuel Prescott. Maps of Paul Revere's Ride X/Twitter – @TheHistoryOfTh2 – https://x.com/TheHistoryOfTh2 Facebook – The History of the Americans Podcast – https://www.facebook.com/HistoryOfTheAmericans Selected references for this episode (Commission earned for Amazon purchases through the episode notes on our website) David Hackett Fischer, Paul Revere's Ride John Hancock's Trunk o' Papers

Are we on the brink of a major shift in research? In this episode of Sounds of Science, Charles River experts challenge traditional approaches, exploring cutting-edge innovations that enhance animal welfare while driving scientific breakthroughs.   From revolutionary non-animal testing methods to advanced behavioral management strategies, we uncover how ethical care leads to better data and faster drug discovery. Tune in to discover how science, compassion, and innovation are shaping the next era of drug development.Show Notes Animals in Research | 3Rs Alternative Methods Advancement Project CHARTER Program for Lab Animal Welfare Advancing Responsible Science 

Did you know that the first attempt at a cancer vaccine was all the way back in the 1800s? I am joined by Charles River experts Louise Brackenbury, Dan Rocca, and Mike Templin to discuss the fascinating science behind therapeutic cancer vaccines.

On April 18, 1775, a Boston-based silversmith, engraver, and staunch anti-British political operative named Paul Revere set out on the most famous horse ride in American history. A century later it inspired the poem and legend of "The Midnight Ride of Paul Revere." But the story is deeper and richer than we've all assumed. Acclaimed writer and editor Kostya Kennedy, through extraordinary and extensive research, has uncovered new and enlightening information on that amazing - including the women who were involved and African Americans in Boston - event presented now in his new book, THE RIDE: Paul Revere and the Night That Saved America (St. Martin's Press, On Sale Date 3/25/25, $30.00). Revere was not the only rider on the night of April 18, 1775, but he was by far the most critical. The Patriots best and most trusted "express rider" he had already completed at least 18 previous rides throughout New England, disseminating intelligence about British movements. But this ride was like no other, and its consequences in the months and years following - as the American Revolution transitioned from isolated skirmishes to a full-fledged war - became one of our founding tales. In THE RIDE, Kostya Kennedy presents a dramatic new narrative of the events of Revere's ride, informed by fresh primary and secondary research into archives, family letters and diaries, contemporary accounts, and more. What he found are never before, or rarely, discussed events, before and after the ride, including: *On the night of the ride, Paul Revere was already the go-to rider for the revolution, called upon to make the most critical rides: in December 1773 he rode hundreds of miles south to New York and Philadelphia to deliver news of The Boston Tea Party.*Revere never said, "The British are coming!" during the ride.*On the night of the ride, Revere rode on a borrowed horse that was then taken from him by British officers; Revere never saw the horse again.*The "sea," in "one if by land, two if by sea," refers to the Charles River.*Revere intentionally did not carry his pistol on the night of the ride, which may have saved his life.*At the start of the ride, Revere was rowed quietly over the Charles River from Boston to Charlestown, along the way eluding lookouts stationed on a British warship.*Other riders galloped through the countryside that night carrying the alarm and nearly all of them were set in motion by Revere's alarm.*Only one other rider departed from Boston, William Dawes, who left over land across Boston Neck; as Dawes got past British guards he pretended he was a drunk country bumpkin. Kennedy's work shows the Revere ride to be vastly more complex than is usually portrayed. It was a coordinated ride of some 40 men that included near-disasters, capture by British forces, and ultimately success. While Paul Revere was central to the ride and its plotting, the author reveals the myriad other men - and women! - who proved crucial to the events that helped set in motion what would lead to America's independence. Thrillingly written in a dramatic heart-stopping narrative, THE RIDE re-tells the essential American story of our nation's awakening for a new generation of readers. Become a supporter of this podcast: https://www.spreaker.com/podcast/arroe-collins-like-it-s-live--4113802/support.

Boston is a city shaped by water. From its earliest Indigenous inhabitants, to its dramatic role in the American Revolution, the city's history is written in its harbours, rivers, and shorelines. But Boston's connection to the water isn't just about the past—it's alive and thriving today. Join host Portia Jones and producer Luke as they explore Boston's famous harbour and its transformation from a strategic trading port to a thriving waterfront destination. Whale tails break the surface in the waters of Stellwagen Bank, an ocean sanctuary teeming with marine life. Kayaks glide past the city skyline, offering a fresh perspective on familiar landmarks. Amphibious vehicles splash into the Charles River on a journey that blurs the line between road and water. From the buzzing harbour to Boston's best waterfront activities, we'll take you beyond the usual sights and into the heart of Boston's relationship with the sea. Along the way, you'll hear from locals who bring these waters to life through conservation, adventure, or the stories of Boston's past Thanks to Meet Boston and TTM World for supporting and collaborating with the Travel Goals podcast. Tune in to discover a side of Boston you've never seen before. ***** Hi, I'm your podcast host, Portia Jones [nicknamed Pip Jones]. I'm a freelance travel journalist, podcaster, and Lonely Planet author.  If you love to travel, check out my travel website and subscribe to my travel newsletter to get travel guides and new episodes of the Travel Goals podcast delivered straight to your inbox. Connect with us on social media: Travel Goals on Instagram | Travel Goals on Facebook  Travel Goals is produced and owned by South Girl Production Music and Podcasting Ltd.  Email us to discuss working together or with any questions about the podcast.  Enjoy the show, and don't forget to leave us a rating and review on Apple Podcasts and Spotify.

A TRUE-ISH STORY: On March 18th, 1990 hundreds of millions of dollars worth of art were stolen from Boston's Isabella Stewart Gardner Museum. This is not that story When Marty (Paul Guilfoyne) ropes Steve into a world of oddballs, misfits, and lost souls as dirty as the Charles River, Steve wonders if it's a change for the better or if he's about to make the worst decision of his life.  Steve Baker (Taylor Gray) is a night watchman in his early 20s, but his life is already slipping away from him. Here's the trailer:  Https://www.youtube.com/watch?v=R3tZL2xVH08 Become a supporter of this podcast: https://www.spreaker.com/podcast/arroe-collins-unplugged-totally-uncut--994165/support.

A TRUE-ISH STORY: On March 18th, 1990 hundreds of millions of dollars worth of art were stolen from Boston's Isabella Stewart Gardner Museum. This is not that story When Marty (Paul Guilfoyne) ropes Steve into a world of oddballs, misfits, and lost souls as dirty as the Charles River, Steve wonders if it's a change for the better or if he's about to make the worst decision of his life.  Steve Baker (Taylor Gray) is a night watchman in his early 20s, but his life is already slipping away from him. Here's the trailer:  Https://www.youtube.com/watch?v=R3tZL2xVH08 Become a supporter of this podcast: https://www.spreaker.com/podcast/arroe-collins-like-it-s-live--4113802/support.

If you see Christine by the Charles River trying to sell you on eternal life... no you didn't.Join our not so secret labor force! https://www.patreon.com/beachtoosandyWe have merch! https://www.beachtoosandy.storeXandy's stream: twitch.tv/xandyschieferWatch clips of your favorite moments! https://www.youtube.com/beachtoosandywatertoowetWatch videos from our episodes on TikTok! https://tiktok.com/@beachtoosandyXtine's Etsy: https://www.etsy.com/shop/thextinefiles Learn more about your ad choices. Visit megaphone.fm/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

If you see Christine by the Charles River trying to sell you on eternal life... no you didn't. Join our not so secret labor force! https://www.patreon.com/beachtoosandy We have merch! https://www.beachtoosandy.store Xandy's stream: twitch.tv/xandyschiefer Watch clips of your favorite moments! https://www.youtube.com/beachtoosandywatertoowet Watch videos from our episodes on TikTok! https://tiktok.com/@beachtoosandy Xtine's Etsy: https://www.etsy.com/shop/thextinefiles Learn more about your ad choices. Visit megaphone.fm/adchoices

Host, reporter, and podcaster Sam Sanders talks with Dylan about the places that have shaped his life – from when he was a kid in a small town in Texas secretively listening to Stevie Wonder in the bathroom, to running along the Charles River, to exploring Joshua Tree National Park with Zora Neale Hurston (kind of).Check out Sam's podcasts Vibe Check and the The Sam Sanders Show.

How can genetic, geographic, and social considerations effect outcomes for Black women with cancer? To answer this question, I am joined this week by Dr. Lauren E. McCullough, Associate Professor in the Department of Epidemiology at the Rollins School of Public Health, and Julia Schueler, Research Director Therapeutic Area Lead Oncology for Charles River. Dr. McCullough is also one of the lead researchers for the American Cancer Society's VOICES of Black Women initiative, which will track the health of participants over several years to gain insight into health considerations for Black women. For more information on how to enroll, please visit voices.cancer.org.

Join Kit and Allison as they discuss Kit's deep-rooted passion for running that began in a pioneering running family of the '70s.Kit shares a fascinating journey through early childhood memories of marathon finish lines, high school wrestling leading to running, and college days running along Boston's Charles River.Discover Kit's accomplishments, including running the Boston Marathon nine times and creating a vibrant and supportive running community in Mobile, Alabama.Kit reflects on lessons learned, the significance of persistence, and the sheer joy of running in community.Learn about Kit's minimalist running routine, preferred races, recovery tools, and inspiring stories of pacing an ultra-marathon friend through a grueling 50 miles.This episode is an inspiring testament to finding solace, strength, and an unbreakable community through running.Kit Ekman - https://www.facebook.com/kit.ekman.5Downtown Runners United by Beers - https://www.facebook.com/groups/924245741471464Races MentionedBoston MarathonMarine Corps MarathonFirst Light MarathonBattleship 12kShout OutsFleet FeetMicaiah RockwellMarjorie RockwellSupport the showFor more details on Run Your Story happenings, including signing up for our upcoming training program, visit https://runyourstory.com/For web development, coding tutoring, or tech services, visit https://gaillardts.com/Go Run Your Story and take a piece of this story with you! Follow us on Facebook and Instagram for the latest news on upcoming episodes. Support me on Patreon!Can't wait to hear Your Run Story!! Thank you to all of our Patreon supporters!Kristen RatherSteve TaylorMary TrufantSuzanne CristSuzanne ClarkAnna SzymanskiDave McDonaldKarla McInnisJames ContrattoJordan DuBoseCristy EvansSharonda ShulaNell GustavsonMeredith NationsAllyson SwannChris Strayhorn

State Police warn Bostonians not to be tempted by the Charles River, Netflix prices are up, and Prince Harry reaches a settlement with British tabloids. Stay in "The Loop" with #iHeartRadio.

Artificial intelligence and machine learning are launching a new era in drug development. By integrating these technologies, researchers can get their life-saving therapies to patients faster thanks to more accurate data and efficient processes.   Join us as Brian Roche, General Manager of Charles River's integrated toxicology site in Kansas, as he discusses the advantages of using these advanced technologies, how their being leveraged across multiple platforms, and what role they play in shaping the future.Show NotesNew Integrated Toxicology Site Kansas Site Unlocking the Promise of Integrated Toxicology: A Tour Through the Lab of the Future Meeting at the Intersection of Technology and Scientific Innovation 

In this episode of the New England Endurance Podcast, we learn about one of largest cycling clubs in the Boston area: the Charles River Wheelmen (CRW). My guest today is Randolph Williams, the President of CRW, an accomplished endurance athlete, and a passionate advocate for inclusivity in cycling.Randolph shares how growing up in a family steeped in social activism shaped his journey, culminating in his impactful essay, Biking While Black. This powerful piece not only highlighted inequalities in the sport but also inspired tangible changes, such as the Wheels of Change Strava Art project.We'll uncover the rich history and mission of CRW, founded over 50 years ago by Dr. Ralph Galen, and explore what makes the club such a cornerstone of the Boston cycling scene. From their inclusive approach and legendary rides to their commitment to promoting camaraderie and belonging, CRW truly embodies the joy of shared cycling adventures.Join us as Randolph talks about his epic solo rides—like Boston to Montreal—as well as how he's helping shape the future of CRW. We'll also discuss CRW's structure, favorite routes, signature events like the Cranberry Century, and the club's role in advocating for better cycling infrastructure in New England.Whether you're a casual cyclist looking for a welcoming community or a seasoned rider chasing epic routes, this club and this episode has something for everyone. Don't miss Randolph's inspiring stories and insights about the power of cycling to build community and create lasting change.Be sure to follow us on Instagram @newenglandendurance for updates and tags from today's episode.Art & Eric embark on a journey to showcase and celebrate the endurance sports community in New England.

As researchers look for ways to reduce the need for animals in their studies, new alternative methods (NAMs) are an intriguing route to capture crucial safety data and help advance drug discovery and development – specifically, virtual control groups (VCGs).   Join Steve Bulera, CVP and Chief Scientific Officer for Safety Assessment and Toxicology at Charles River, as he discusses how VCGs can be a viable alternative to research models, what it would take for the industry to widely accept NAMs, and how they can revolutionize research for the future.Show NotesVirtual Control Groups  Sounds of Science E73: Virtual Control Groups Modernizing Drug Development with Virtual Control Groups Virtual Control Groups: A Data-Driven Novel Method Revolutionizing the Future of Safety Studies Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals 

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Kerstin Dolph, Senior Vice President of Manufacturing at Charles River Laboratories. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kerstin, covering: The value of having managers and mentors guide you and champion your success Navigating transitions from finance to operations and research to biologics manufacturing while becoming a senior leader at CRL Tackling the task of integrating testing and manufacturing at CRL globally to cut timelines for clients The importance of staying close and connected to the patient so you never lose sight of the impact of the work done in this space Stabilizing signs in the biotech market and pivoting to the market's needs in creative ways Kerstin joined Charles River 2001 in a Finance role for the Company's Research Models and Services (RMS) business in Germany. She transitioned to the U.S. RMS business in 2009 and was promoted to Senior Finance Director of Global RMS in 2015. In 2017, Ms Dolph was promoted to Corporate Vice President of North American RMS, responsible for leading the Company's North American RMS business. This included managing several consolidation and efficiency initiatives and global RMS technology enhancements. In 2019, Ms Dolph assumed the role of Corporate Vice President of Global Biologics. Subsequently, she assumed responsibility for the Company's CDMO business and was promoted to senior vice president of biologics solutions in October 2021. Ms. Dolph is currently the Senior Vice President of Manufacturing. She is responsible for driving each business's strategic direction and future growth within the Company's Manufacturing Solutions segment, including Biologics Testing Solutions, CDMO, and Microbial Solutions. Ms. Dolph holds a bachelor's degree from the International Accountancy & Business School in Wuerzburg, Germany and was recognised by the Bavarian Government for outstanding performance.   This episode of Molecule to Market is sponsored by Vetter, a global leader in aseptic filling solutions for injectable products in the pharmaceutical and biotech industries. Discover more about Vetter's comprehensive services, from early-stage development to commercial production, and how they support clients in delivering high-quality therapies to the market. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.

On the morning of January 5, 1994, 27-year-old David Cox, a former Marine whose story inspired the movie A Few Good Men, was at home, anxiously awaiting news about a potential full-time job. But when his girlfriend, Elaine, returned home that evening, David was nowhere to be found. His truck was parked outside, with the keys in the ignition and an uncashed paycheck sitting on the dashboard. Despite these strange circumstances, police initially believed David had run off. However, nearly three months later, his body was discovered along a Medfield, Massachusetts riverbank five miles from his apartment. He had been shot four times. Despite a thorough investigation, no motive or suspects have been identified, leaving David's family desperate for answers. It's been over 30 years since David's murder, and investigators are still searching for the person responsible... On the morning of January 5, 1994, David Cox went missing from his apartment in Natick, Massachusetts. Almost three months later, on April 2, his body was discovered along the Charles River in Medfield, about five miles from his home. At the time of his death, David was wearing a Marine Corps camouflage jacket over a black hooded Marines sniper jacket, along with jeans and sneakers. If you have any information about David's murder, please call the Massachusetts State Police detectives assigned to David's case at 617-593-8840. Editor: Shannon Keirce Research/Writing: Haley Gray and Anna Luria SUBMIT A CASE HERE: Cases@DetectivePerspectivePod.com SOCIAL Instagram: https://www.instagram.com/detperspective/ Twitter: https://twitter.com/detperspective FIND DERRICK HERE Twitter: https://twitter.com/DerrickL Instagram: https://www.instagram.com/DerrickLevasseur Facebook: https://www.facebook.com/DerrickVLevasseur CRIME WEEKLY AND COFFEE Criminal Coffee Company: https://www.CriminalCoffeeCo.com Crime Weekly:  https://crimeweeklypodcast.com/shop ADS: 1. TryMiracle.com/Detective - Use code DETECTIVE for 3 FREE towels and to save over 40% on your next order! 2. MagicMind.com/Perspective - Use code PERSPECTIVE to get up to 48% off your first subscription! 

When author Frances McNamara isn't "sailing on the Charles River in Boston or beaching on Cape Cod," she's dropping red herrings & killing characters living in 1890s Chicago. Join us as we talk about "Death at Hull House," McNamara's second Emily Cabot Mystery. This former librarian has a brand (Progressive-era crime solving in Illinois) and we respect it. Grab a spare chair from a settlement  house near you and settle in for a discussion on death, intrigue, and smallpox. Curious about what's coming next? We will be reading A Journey to the New World: The Diary of Remember Patience Whipple, Mayflower, 1620 See you in September.   Original air date: August 30, 2020

Dr. Lisa Jones Engel, PETA Primatologist explains the significance of PETA's collaboration with the people of  Brazoria County, Texas, to stop Charles River from building a facility that would hold 43, 000 monkeys. In conversation with Emil Guillermo. Take action, save the chimps. Go to  PETA.org The PETA Podcast PETA, the world's largest animal rights organization with all its global entities, is 9 million strong and growing. This is the place to find out why. Hear from insiders, thought leaders, activists, investigators, politicians, and others why animals need more than kindness—they have the right not to be abused or exploited in any way. Hosted by Emil Guillermo. Powered by PETA activism.  Contact us at PETA.org Listen to the very first PETA podcast with Ingrid Newkirk Music provided by CarbonWorks. Go to Apple podcasts and subscribe.  Contact and follow host Emil Guillermo on  X@emilamok Or at www.amok.com Get this podcast at www.YouTube.com/@emilamok1 Please subscribe, rate and review wherever you get your podcasts.  Thanks for listening to THE PETA PODCAST!  (Originally released Sept. 24 2024  ©copyright 2024  

(00:00) When things go wrong sometimes on the Howard Stern Show, what should you do in these times of crisis? Why try to do live music when you never know how it will go?(17:42) Dave Richard joins and breaks down his best picks in fantasy football for this upcoming season. Fading CeeDee Lamb? High on backup RBs? All you need to know and more to win your league!(30:46) Nothing tastier than some fresh, yummy, rust-colored tap water straight from the Charles River! Maybe that's what's replacing coffee for Toucher and Hardy early in the morning. CONNECT WITH TOUCHER & HARDY: linktr.ee/ToucherandHardy For the latest updates, visit the show page on 985thesportshub.com. Follow 98.5 The Sports Hub on Twitter, Facebook, and Instagram. Watch the show every morning on YouTube, and subscribe to stay up-to-date with all the best moments from Boston's home for sports!